120. Hereditary dystonia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 26 / Drugs : 19 - (DrugBank : 3) / Drug target genes : 2 - Drug target pathways : 2
Hereditary dystonia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 120 | Hereditary dystonia | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 2.000 |
| 179 | Williams syndrome | 2.000 |
| 6 | Parkinson disease | 2.000 |
| 299 | Cystic fibrosis | 2.000 |
| 17 | Multiple system atrophy | 2.000 |
| 46 | Malignant rheumatoid arthritis | 2.000 |
| 49 | Systemic lupus erythematosus | 2.000 |
| 8 | Huntington disease | 2.000 |
| 156 | Rett syndrome | 2.000 |
| 78 | Hypopituitarism | 2.000 |
| 97 | Ulcerative colitis | 2.000 |
| 206 | Fragile X syndrome | 2.000 |
| 226 | Interstitial cystitis with Hunners ulcer | 2.000 |
| 18 | Spinocerebellar degeneration | 2.000 |